Lung Cancer
Multidisciplinary oncology care including immunotherapy and targeted treatment for lung cancer.
About this Treatment
Cuba's Lung Cancer program is internationally recognized for CIMAvax-EGF, a Cuban-developed therapeutic vaccine that targets epidermal growth factor to extend survival in non-small-cell lung cancer. Treatment integrates surgery, chemotherapy, radiotherapy, and immunotherapy through a multidisciplinary approach.
Symptoms
Persistent cough; coughing up blood; chest pain; shortness of breath; hoarseness; recurrent infections; unexplained weight loss; fatigue.
Treatment Benefits
Access to CIMAvax-EGF and other Cuban immunotherapies; multidisciplinary oncology team; integrated conventional and immunotherapy; survival and quality-of-life focus; experienced thoracic specialists; international patient support.
Candidate Criteria
Patients with confirmed lung cancer diagnosis; suitable for immunotherapy or combined treatment; adequate general condition (performance status). Biopsy pathology, CT/PET imaging required.
Procedure Overview
1) Oncology consultation and staging (CT, PET, biopsy). 2) Multidisciplinary treatment plan (surgery, chemo, radiotherapy, immunotherapy). 3) Treatment per protocol. 4) CIMAvax-EGF vaccination series for eligible NSCLC patients. 5) Response monitoring and surveillance.
Recovery Timeline
Surgery: 4–8 weeks recovery; chemo/radiotherapy courses over months; CIMAvax series over 1–2 years; long-term surveillance.
Risks & Considerations
Surgical risks (pneumonia, prolonged air leak); chemo/radiotherapy side effects; immunotherapy reactions; disease progression in advanced cases.
Aftercare & Follow-up
Imaging surveillance schedule; pulmonary rehabilitation; symptom management; smoking cessation support; coordination with home oncologist; long-term follow-up.
Your Patient Journey
- 1
Consultation
- 2
Staging
- 3
Treatment Planning
- 4
Treatment
- 5
Immunotherapy
- 6
Surveillance
Why Choose Cuba for Lung Cancer
Internationally recognized biotechnology
Cuba pioneered breakthroughs like Heberprot-P®, used worldwide for diabetic foot ulcers.
Highly experienced specialists
Board-certified doctors trained in Cuba's acclaimed medical education system.
Affordable all-inclusive packages
From $9,500 (treatment program including immunotherapy)
Personalized patient support
Dedicated coordinators assist you from first inquiry through recovery.
Related Treatments
Frequently Asked Questions
Common questions from patients considering this treatment. Still unsure? Contact our team anytime.